As a global pharmaceutical company, Astellas takes the fight against cancer personally and is deeply committed to our employees and customers who are a part of the oncology community. Fifty...

Astellas Executive Vice President and Head of Medical Affairs Shontelle Dodson and Vice President, Head of Biopharma Development Marci English were recently featured in an Axios Smart Brevity...

Astellas provides biopharma industry experience for PharmD students When Astellas learned that the Chicago State University College of Pharmacy did not offer a biopharma industry rotation as part...

Astellas congratulates Judy Kannenberg, Vice President, Regulatory Affairs Therapeutic Area Head of Medical Specialties, for being named a 2023 Healthcare Businesswomen’s Association (HBA)...

Astellas was recently ranked in Seramount’s 2022 list of 100 Best Companies and Best Companies for Dads highlighting our commitment to creating a workplace where working parents are valued and...

Astellas ranked again in Seramount’s 2022 “100 Best Companies” list and Best Companies for Dads

C3 Prize Winner Shares How Her Father’s Experience with Cancer Inspired Her to Create New Patient App Astellas Pharma senior vice president and global head of Patient Centricity Dr. Anthony...

Great Place to Work® and Fortune magazine have honored Astellas as one of the 2022 Best Workplaces in BioPharma™. This is Astellas’ first time being named to this prestigious list, coming in...

Our consistent score of 100 recognizes our continuing effort to create an inclusive culture for people with disabilities. For the third year in a row, Astellas has been included in the Disability...

Astellas Pharma US President Mark Reisenauer recently joined PhRMA Senior Vice President of State Advocacy Scott LaGanga for a conversation about a range of topics that are important to patients...